IO Biotech – Corporate website for a phase 3 Biotech company
A new and secure corporate website for a biotech company that was on it's way to the NASDAQ
The Client
IO Biotech is a publicly traded Phase 3 biotech company developing novel, immune-modulating cancer therapies based on their T-win® technology platform.
As of November 5, 2021, IO Biotech is listed on the NASDAQ. A launch on the stock market that we have been working towards together with the IO Biotech team.
The Challenge
Leading up to their IPO, the IO Biotech team was looking for a permanent party to take on web development. This is how our conversations started with Mikkel Dybkjær, then VP of Corporate Finance.
During our conversations, it quickly became clear that their old Joomla website was in need of a thorough overhaul. The IO Biotech team was also looking for more than just a website builder. In the Biotech world, things move fast. Therefore, for a company like IO Biotech, website maintenance and quick support after launch are high on the wish list.
Our Solution
Our proposal was warmly received. We chose a custom design for IO Biotech, built in the WordPress CMS.
Between the corporate and investor relations sites, we created an integration that automatically synchronizes news items.
The Result
We launched the revamped IO Biotech website more than 2 months before their IPO, the final deadline.
In addition, the entire IO Biotech team enjoys prompt follow-up on all their inquiries. We even realize now, almost a year after website launch, updates and publication of press releases on the same business day of request.
Finally, the website is in good hands. After 10,000’s of hacking attempts, which is not uncommon for a biotech company, the website is as squat as it was at launch. This is thanks to our weekly maintenance, strict security measures and a real-time firewall.
